-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RuH3q3tqRv+rVgPQHq7fT1GrqwYHxtyHhCuJ/qm+7xk1HgnaG8BUDwGTXJx/kUWy fzB0Dx7ejiHxAebO16qLVg== 0000885988-05-000114.txt : 20050803 0000885988-05-000114.hdr.sgml : 20050803 20050803170629 ACCESSION NUMBER: 0000885988-05-000114 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050803 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20050803 DATE AS OF CHANGE: 20050803 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRAMED AMERICA INC CENTRAL INDEX KEY: 0000885988 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 061150326 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-20260 FILM NUMBER: 05996434 BUSINESS ADDRESS: STREET 1: TWO MANHATTANVILLE RD CITY: PURCHASE STATE: NY ZIP: 10577-2100 BUSINESS PHONE: 9142538000 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE RD CITY: PURCHASE STATE: NY ZIP: 10577-2100 FORMER COMPANY: FORMER CONFORMED NAME: IVF AMERICA INC DATE OF NAME CHANGE: 19950720 8-K 1 form8k08032005.txt INTEGRAMED AMERICA, INC. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act 1934 Date of Report (Date of earliest event reported): August 3, 2005 INTEGRAMED AMERICA, INC. - ------------------------------------------------------------------------------- (Exact name of registrant as specified in charter) Delaware - ------------------------------------------------------------------------------- (State of other jurisdiction of incorporation) 0-20260 6-1150326 - ------------------------------------------------------------------------------- (Commission File Numbers) (IRS Employer Identification No.) Two Manhattanville Road, Purchase, NY 10577 - ------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone no. including area code: (914) 253-8000 -------------- (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communication pursuant to Rule 425 under the Securities Act (17 ___ CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 ___ CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the ___ Exchange Act (17 CFR 240.14d-2(b) Pre-commencement communication pursuant to Rule 13e-4(c) under the ___ Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 Regulation FD Disclosure Registrant's Press Release dated August 3, 2005 attached as Exhibit 99.91 hereto is furnished pursuant to Regulation FD; it is not filed. ITEM 9.01. Financial Statements, Pro Forma Financial Information and Exhibits (c) Exhibits Exhibit No. Description of Exhibit ----------- ---------------------- 99.91 Registrant's Press Release dated August 3, 2005 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. INTEGRAMED AMERICA, INC. (Registrant) Date: August 3, 2005 By: /s/John W. Hlywak, Jr. ----------------------------------- John W. Hlywak, Jr. Sr. Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) EX-99 3 exhibit9991.txt INTEGRAMED AMERICA, INC. John W. Hlywak, Jr. (Investors) Jay Higham (Media) Senior Vice President & CFO President & COO IntegraMed America, Inc. IntegraMed America, Inc. (914) 251-4143 (914) 251-4127 email: jhlywak@integramed.com email: jhigham@integramed.com ---------------------- ---------------------- Web Address: http://www.integramed.com ------------------------- INTEGRAMED INCLUDED IN NEW NASDAQ HEALTH CARE INDEX Purchase, NY, August 3, 2005 -- IntegraMed America, Inc. (Nasdaq: INMD) today announced that it has been selected for inclusion in the new NASDAQ Health Care Index. On July 27, 2005, the NASDAQ Strategy Index Group announced the new NASDAQ Health Care Index and named IntegraMed America as a founding member of the Index. The NASDAQ Health Care Index is a market value weighted index that contains NASDAQ-listed companies classified, according to the FTSE Global Classification System, as "Health", "Pharmaceutical", or "Biotechnology". These classifications include health maintenance organizations, hospital management and long-tern care, medical equipment and supplies, other health care, biotechnology and pharmaceutical companies. The NASDAQ Health Care Index is now a part of the broad selection of world-class indexes such as the NASDAQ-100 Index and the NASDAQ Biotechnology Index. "We are pleased to be included in the new NASDAQ Health Care Index as it provides market participants new opportunities to own shares of IntegraMed through an additional investment vehicle", commented Gerardo Canet, Chairman and Chief Executive Officer of IntegraMed America, Inc. About IntegraMed America, Inc. IntegraMed, based in Purchase, NY offers products and services to patients, providers and payers focused on the $2 billion fertility industry. IntegraMed provides business services to a national network of fertility centers; distributes pharmaceutical products and treatment financing programs directly to consumers; and operates http://www.integramed.com, a leading fertility portal. Statements contained in this press release that are not based on historical fact, including statements concerning future results, performance, expectations and expansion of IntegraMed America are forward-looking statements that may involve a number of risks and uncertainties. Actual results may differ materially from the statements made as a result of various factors, including, but not limited to, the risks associated with the Company's ability to finance future growth; the loss of significant business service contract(s); profitability at Reproductive Science Centers serviced by IntegraMed America; changes in insurance coverage, government laws and regulations regarding health care or managed care contracting; and other risks, including those identified in the Company's most recent Form 10-K and in other documents filed by the Company with the U.S. Securities and Exchange Commission. All information in this press release is as of August 3, 2005 and IntegraMed undertakes no duty to update this information. # # # # -----END PRIVACY-ENHANCED MESSAGE-----